Laver TW, Wakeling MN, Knox O, Colclough K, et al. Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY. Diabetes 2022;71:1128-1136.
PMID: 35108381